Assessment of serum levels of asymmetric dimethylarginine, symmetric dimethylarginine andl-arginine in coronary artery disease

Mohamed Z. Gad, Sally I. Hassanein, Sahar M. Abdel-Maksoud, Gamal M. Shaban, Khaled Abou-Aisha, Hossam A. Elgabarty
2010 Biomarkers  
Serum asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA), l-arginine, and C-reactive protein (hsCRP) levels were assessed in 100 Egyptian male 35-50-year-old patients with coronary artery disease (CAD), classified into: patients under conservative medical treatment, patients directed for percutaneous coronary interventions, patients directed for coronary artery bypass graft operation and patients suffering from acute myocardial infarction. Age-and sex-matched controls (n =
more » ... ed controls (n = 100) were included. Correlation between serum levels of biomarkers and dimethylarginine dimethylaminohydrolase-2 (DDAH-2) genotypes was studied. No association between biomarkers and carriage of the specific DDAH2 SNP2 (-449C/G, rs805305) genotype was detected. Further studies are required to confirm the contribution of the biomarkers in the predisposition of CAD.
doi:10.3109/1354750x.2010.519784 pmid:20936901 fatcat:efttwpjivjdnxklx6kifbermzy